We are live on ! Find out more
V

Veritable Portfolio holdings

AUM $6.46B
1-Year Est. Return 17.32%
This Fund
S&P 500
This Quarter Est. Return
-4.02%
1 Year Est. Return
+17.32%
3 Year Est. Return
+48.78%
5 Year Est. Return
+62.03%
10 Year Est. Return
+162.29%
AUM
$6.51B
AUM Growth
-$239M
Cap. Flow
+$75.8M
Cap. Flow %
1.16%
Top 10 Hldgs %
56.15%
Holding
962
New
53
Increased
520
Reduced
231
Closed
56

Top Buys

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$13.8M
2
IJH icon
iShares Core S&P Mid-Cap ETF
IJH
+$9.92M
3
VEU icon
Vanguard FTSE All-World ex-US ETF
VEU
+$8.47M
4
VOO icon
Vanguard S&P 500 ETF
VOO
+$7.92M
5
VONE icon
Vanguard Russell 1000 ETF
VONE
+$7.44M

Top Sells

Rank Stock Value
1
NAD icon
Nuveen Quality Municipal Income Fund
NAD
+$20.5M
2
CMCSA icon
Comcast
CMCSA
+$10.1M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$4.79M
4
SCHD icon
Schwab US Dividend Equity ETF
SCHD
+$3.88M
5
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$3.35M

Sector Composition

Rank Sector Weight
1 Technology 6.37%
2 Financials 4.89%
3 Healthcare 3.44%
4 Consumer Staples 2.64%
5 Communication Services 2.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PRTY
876
DELISTED
Party City Holdco Inc.
PRTY
$145K ﹤0.01%
+40,640
New +$184K
PAA icon
877
Plains All American Pipeline
PAA
$17.4B
$144K ﹤0.01%
13,369
+1
+0% +$11
ELMS
878
DELISTED
Electric Last Mile Solutions, Inc. Class A Common stock
ELMS
$144K ﹤0.01%
100,600
+50,300
+100% +$164K
PLTR icon
879
Palantir
PLTR
$295B
$142K ﹤0.01%
+10,376
New +$138K
BLDP
880
Ballard Power Systems
BLDP
$874M
$135K ﹤0.01%
+11,585
New +$123K
ELDN icon
881
Eledon Pharmaceuticals
ELDN
$276M
$130K ﹤0.01%
33,092
– –
LUMN icon
882
Lumen
LUMN
$6.53B
$128K ﹤0.01%
+11,336
New +$130K
PRAX icon
883
Praxis Precision Medicines
PRAX
$9.07B
$122K ﹤0.01%
794
– –
DTIL icon
884
Precision BioSciences
DTIL
$188M
$120K ﹤0.01%
1,297
+467
+56% +$63.4K
VIRX
885
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$118K ﹤0.01%
+24,836
New +$74.8K
AM icon
886
Antero Midstream
AM
$10.8B
$117K ﹤0.01%
10,718
-1,580
-13% -$16K
VINC
887
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
$116K ﹤0.01%
1,454
– –
DBRG icon
888
DigitalBridge
DBRG
$2.94B
$113K ﹤0.01%
3,940
-29
-0.7% -$845
LBPH
889
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
$110K ﹤0.01%
20,534
– –
GANX icon
890
Gain Therapeutics
GANX
$74.6M
$103K ﹤0.01%
25,064
– –
XELB icon
891
Xcel Brands
XELB
$7.45M
$82K ﹤0.01%
5,534
– –
CLNN icon
892
Clene
CLNN
$68.9M
$79K ﹤0.01%
+1,000
New +$60.5K
CABA icon
893
Cabaletta Bio
CABA
$439M
$76K ﹤0.01%
37,245
+26,745
+255% +$69.9K
AMRS
894
DELISTED
Amyris Inc.
AMRS
$65K ﹤0.01%
15,000
– –
FRLN
895
DELISTED
Freeline Therapeutics Holdings plc American Depositary Shares
FRLN
$63K ﹤0.01%
3,725
– –
KGC icon
896
Kinross Gold
KGC
$28.5B
$59K ﹤0.01%
10,000
– –
SREV
897
DELISTED
ServiceSource International, Inc.
SREV
$57K ﹤0.01%
43,661
– –
QVCGA
898
DELISTED
QVC Group Inc Series A
QVCGA
$48K ﹤0.01%
+201
New +$64.1K
FIRY
899
Firy Inc
FIRY
$127M
$42K ﹤0.01%
+702
New +$57.2K
FNHC
900
DELISTED
FedNat Holding Company Common Stock
FNHC
$41K ﹤0.01%
30,000
– –
34 35
36
37 38

Similar funds

PI
PFS Investments Duluth, Georgia $6.12B AUM 12.74% 1-Year Est. Return
WI
Winder Investment Singapore $4.4B AUM 8.87% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
VIA
Vident Investment Advisory Alpharetta, Georgia $2.9B AUM 24.67% 1-Year Est. Return
EST
EA Series Trust Havertown, Pennsylvania $2.84B AUM
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
AWS
AJ Wealth Strategies New York $2.07B AUM 10.86% 1-Year Est. Return
JP
Jana Partners New York $1.34B AUM 4.95% 1-Year Est. Return

Veritable's Q1 2022 Portfolio in Review

As of Q1 2022, Veritable held 962 positions worth $6.51B, down 3.5% from $6.75B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Veritable's Q1 2022 filing shows 53 new, 520 increased, 231 reduced and 56 closed positions. Its largest new stake was Proterra Inc. Common Stock: 306,301 shares worth $2.3M. The largest sale was Nuveen Quality Municipal Income Fund, an estimated $20.5M.

By sector, the portfolio is most concentrated in Technology at 6.4% of assets, down from 6.6% a quarter earlier, followed by Financials and Healthcare.

  • Veritable's largest Q1 2022 buy was Proterra Inc. Common Stock: 306,301 shares worth $2.3M.
  • Veritable added most to iShares Russell 2000 ETF in Q1 2022, an estimated $13.8M increase.
  • Veritable's biggest Q1 2022 reduction was Nuveen Quality Municipal Income Fund, cutting an estimated $20.5M.
  • Veritable fully exited Xilinx Inc in Q1 2022, selling an estimated $2.58M.
  • Veritable's ten largest holdings make up 56% of its $6.51B portfolio in Q1 2022.
  • Veritable opened 53 new positions and closed 56 in Q1 2022.
  • Veritable's portfolio value fell 3.5% quarter-over-quarter to $6.51B.

Based on Veritable's 13F filing for Q1 2022, filed 11 May 2022.